Search

everythinglearnresearchcommunity

for

Search:↓

Obesity is linked to more severe lower urinary tract symptoms.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Finasteride effectively treats baldness but may cause sexual side effects.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Certain drugs that block specific enzymes can help treat prostate diseases.